✦ LIBER ✦

Molecular testing in malignant melanoma

✍ Scribed by Allie H. Grossmann; Kenneth F. Grossmann; Michelle L. Wallander

Book ID: 111888483
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 443 KB
Volume: 40
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.22810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of molecular staging in maligna

The role of molecular staging in malignant melanoma

✍ R.S. Prichard; B. Dijkstra; E.W. McDermott; A.D.K. Hill; N.J. O'Higgins 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

DNCB skin test in cases of malignant mel

DNCB skin test in cases of malignant melanoma

✍ F. Ehring; H. Loth 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 149 KB

Prognostic molecular biomarkers for cuta

Prognostic molecular biomarkers for cutaneous malignant melanoma

✍ Ryo Tanaka; Kazuo Koyanagi; Norihiko Narita; Christine Kuo; Dave S.B. Hoon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Levamisole-Induced Adverse Reactions and

Levamisole-Induced Adverse Reactions and Histocompatibility Testing in Malignant Melanoma

✍ Luis R. Espinoza; Guerin Dorval; C. K. Osterland 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Predictive chemosensitivity testing in m

Predictive chemosensitivity testing in malignant melanoma: reliable methodology – ineffective drugs

✍ Tveit, KM; Gundersen, S; Høie, J; Pihl, A 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 725 KB

Molecular prognostic markers in intermed

Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma

✍ Tina J. Hieken; Salve G. Ronan; Miguel Farolan; Anne L. Shilkaitis; Tapas K. Das 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

## Background: The limitations of morphologic criteria alone in determining the prognosis for a patient with a particular intermediate-thickness primary melanoma have prompted efforts to identify other markers. ## Methods: In this study, the authors analyzed expression of p53, beta1 integrin, and